JAMP Pharma’s growth supported by Fonds de solidarité FTQ
Boucherville, Quebec – October 25, 2016 — JAMP Pharma, a Boucherville based generic pharmaceutical company, announces that it has reached a partnership agreement with the Fonds de solidarité FTQ. This partnership includes a major investment representing a minority participation of 31%. This is a decisive shift in JAMP Pharma’s growth, since it will provide the company with the means to pursue its goals, as well as giving its management team the latitude to achieve them.
To read more, see the press release